Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
about
European Heart Journal-Cardiovascular Pharmacotherapy in 2016: entering a new level of international recognition.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.Aspirin wears smart.2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
P2860
Proton pump inhibitor use by aspirin-treated coronary artery disease patients is not associated with increased risk of cardiovascular events.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Proton pump inhibitor use by a ...... risk of cardiovascular events.
@en
Proton pump inhibitor use by a ...... risk of cardiovascular events.
@nl
type
label
Proton pump inhibitor use by a ...... risk of cardiovascular events.
@en
Proton pump inhibitor use by a ...... risk of cardiovascular events.
@nl
prefLabel
Proton pump inhibitor use by a ...... risk of cardiovascular events.
@en
Proton pump inhibitor use by a ...... risk of cardiovascular events.
@nl
P2093
P2860
P356
P1476
Proton pump inhibitor use by a ...... risk of cardiovascular events.
@en
P2093
Emily D Parker
Laura A Fortuna
Nicole K Trower
Pamala A Pawloski
Thomas E Kottke
P2860
P356
10.1093/EHJCVP/PVV036
P577
2015-09-07T00:00:00Z